Phoenix Life Sciences International Limited announced that Michael Gobel has joined as the company’s Board of Directors to help the company navigate the next steps for larger capital investment and compliance for a planned uplisting to NASDAQ. Gobel serves as Company Director and Portfolio Manager, managing investments and associated risk in local and overseas equity markets. Additionally, Gobel currently serves as a consultant on economic developments and major projects while also representing a variety of interests to federal ministers and senior government advisors. Michael is on a number of Boards including as Deputy Chairman of an Australian Bank, assisting in guiding the company’s corporate governance and strategy, ensuring best practices and encouraging a culture of proactive risk management.